WES: Whole Exome Sequencing Analytical Validation (MD Anderson)
BRD ID: 3119
Tier: SOP
Source: CIMAC-CIDC Network
Number of times downloaded: 385
Description
This assay analytical validation and performance report describes the methods used to validate the Whole Exome Sequencing (WES) assay for the analysis of fresh frozen and formalin-fixed, paraffin-embedded (FFPE) tumor tissue and peripheral blood mononuclear cells (PBMCs). The document also presents data supporting the reported inter- and intra-assay reproducibility, concordance in mutation calls between FFPE and frozen specimens, reproducibility, and sensitivity and specificity. It is performed at the Cancer Immune Monitoring and Analysis Center (CIMAC) at MD Anderson Cancer Center. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).
Biospecimens
CellWhite Cells
TissueLung
Diagnoses
NeoplasticCarcinoma
Topics
Analyte Extraction and Purification
Platform-specific Methodology